Topic

Cigna

A collection of 1135 issues

How to Get Tavalisse (fostamatinib) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tavalisse (fostamatinib) Covered by Cigna in New Jersey Tavalisse (fostamatinib) requires prior authorization from Cigna and is typically covered as a specialty medication for chronic ITP after failed first-line treatments. Your fastest path to approval: 1) Have your hematologist document inadequate response to corticosteroids, IVIG, or TPO
5 min read

Do You Qualify for Hetlioz (Tasimelteon) Coverage by Cigna in North Carolina? Decision Tree & Next Steps

Answer Box: Qualifying for Hetlioz (Tasimelteon) Coverage You likely qualify for Cigna coverage of Hetlioz (tasimelteon) in North Carolina if you have: * Confirmed Non-24-Hour Sleep-Wake Disorder or Smith-Magenis Syndrome diagnosis * Sleep specialist evaluation with 14+ days of sleep logs/actigraphy * Documentation of failed alternative treatments (if step therapy applies) Fastest
6 min read

How to Get Vyondys 53 (Golodirsen) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Cigna requires prior authorization for Vyondys 53 (golodirsen) with genetic testing confirming exon 53-skippable DMD mutation, specialist prescription, baseline kidney function tests, and 6+ months of steroid stabilization. Submit through Express Scripts specialty pharmacy portal. If denied, Washington residents have 180 days for internal appeals, then external review
7 min read

How to Get Keppra (Levetiracetam) Covered by Cigna in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Keppra (Levetiracetam) Covered by Cigna in Pennsylvania Most Cigna plans in Pennsylvania cover generic levetiracetam without prior authorization, but brand Keppra typically requires a formulary exception showing medical necessity. Your fastest path: Have your doctor submit a prior authorization through CoverMyMeds with documentation that generic versions failed
5 min read